Metabolic pathways involved in Xin-Ke-Shu protecting against myocardial infarction in rats using ultra high-performance liquid chromatography coupled with quadrupole time-of-flight mass spectrometry.

[1]  A. Zhang,et al.  Recent advances in metabolomics in neurological disease, and future perspectives , 2013, Analytical and Bioanalytical Chemistry.

[2]  A. Yashin,et al.  The role of lipid‐related genes, aging‐related processes, and environment in healthspan , 2013, Aging cell.

[3]  Arya M. Sharma,et al.  Uric Acid as a Risk Factor for Cardiovascular Disease and Mortality in Overweight/Obese Individuals , 2013, PloS one.

[4]  M. Nahrendorf,et al.  Leukocyte Behavior in Atherosclerosis, Myocardial Infarction, and Heart Failure , 2013, Science.

[5]  William E. Kraus,et al.  Metabolomic Profiling for the Identification of Novel Biomarkers and Mechanisms Related to Common Cardiovascular Diseases: Form and Function , 2012, Circulation.

[6]  A. Clark,et al.  The potential role of sphingolipid-mediated cell signaling in the interaction between hyperglycemia, acute myocardial infarction and heart failure , 2012, Expert opinion on therapeutic targets.

[7]  S. Hazen,et al.  Translating metabolomics to cardiovascular biomarkers. , 2012, Progress in cardiovascular diseases.

[8]  J. Asara,et al.  A positive/negative ion–switching, targeted mass spectrometry–based metabolomics platform for bodily fluids, cells, and fresh and fixed tissue , 2012, Nature Protocols.

[9]  Z. Lou,et al.  Hydrophilic interaction and reversed-phase ultraperformance liquid chromatography TOF-MS for serum metabonomic analysis of myocardial infarction in rats and its applications. , 2012, Molecular bioSystems.

[10]  A. Clark,et al.  Environmental and genetic perturbations reveal different networks of metabolic regulation , 2011, Molecular systems biology.

[11]  Zhang Tao-tao,et al.  Antiatherogenic and Anti-Ischemic Properties of Traditional Chinese Medicine Xinkeshu via Endothelial Protecting Function , 2011, Evidence-based complementary and alternative medicine : eCAM.

[12]  H. Jia,et al.  Qualitative and quantitative characterization of chemical constituents in Xin-Ke-Shu preparations by liquid chromatography coupled with a LTQ Orbitrap mass spectrometer. , 2011, Journal of pharmaceutical and biomedical analysis.

[13]  J. Knuuti,et al.  Metabolic remodelling in human heart failure. , 2011, Cardiovascular research.

[14]  Michael D Reily,et al.  Advances in mass spectrometry applied to pharmaceutical metabolomics , 2011, Analytical and bioanalytical chemistry.

[15]  C. Serhan,et al.  Novel lipid mediators promote resolution of acute inflammation: impact of aspirin and statins. , 2010, Circulation research.

[16]  P. Hu,et al.  Metabolomic profiling of rat serum associated with isoproterenol-induced myocardial infarction using ultra-performance liquid chromatography/time-of-flight mass spectrometry and multivariate analysis. , 2009, Talanta.

[17]  Y James Kang,et al.  Herbogenomics: From Traditional Chinese Medicine to Novel Therapeutics , 2008, Experimental biology and medicine.

[18]  P. S. M. Prince,et al.  Preventive effect of (-)epigallocatechin-gallate (EGCG) on lysosomal enzymes in heart and subcellular fractions in isoproterenol-induced myocardial infarcted Wistar rats. , 2008, Chemico-biological interactions.

[19]  D. Galaris,et al.  Uric acid and oxidative stress. , 2005, Current pharmaceutical design.

[20]  Z. Tulassay,et al.  Plasma carnitine ester profile in adult celiac disease patients maintained on long-term gluten free diet. , 2005, World journal of gastroenterology.

[21]  A. Nilsson,et al.  Arachidonic acid and ischemic heart disease. , 2005, The Journal of nutrition.

[22]  H. Campos,et al.  Arachidonic acid in adipose tissue is associated with nonfatal acute myocardial infarction in the central valley of Costa Rica. , 2004, The Journal of nutrition.

[23]  Lan Mao,et al.  Important role of endogenous norepinephrine and epinephrine in the development of in vivo pressure-overload cardiac hypertrophy. , 2001, Journal of the American College of Cardiology.

[24]  E. Hoffman,et al.  Medium Chain Acyl-CoA Dehydrogenase Deficiency in Pennsylvania: Neonatal Screening Shows High Incidence and Unexpected Mutation Frequencies , 1995, Pediatric Research.

[25]  G. Lopaschuk,et al.  The 1993 Merck Frosst Award. Acetyl-CoA carboxylase: an important regulator of fatty acid oxidation in the heart. , 1994, Canadian journal of physiology and pharmacology.

[26]  N. Katunuma,et al.  Effects of selective inhibition of cathepsin B and general inhibition of cysteine proteinases on lysosomal proteolysis in rat liver in vivo and in vitro. , 1992, European journal of biochemistry.

[27]  M. Goodman,et al.  Radioiodinated 15-(p-iodophenyl)-3,3-dimethylpentadecanoic acid: a useful new agent to evaluate myocardial fatty acid uptake. , 1986, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[28]  B. Wexler,et al.  Protective effects of clofibrate on isoproterenol-induced myocardial infarction in arteriosclerotic and non-arteriosclerotic rats. , 1978, Atherosclerosis.

[29]  B. Wexler.  Protective effects of propranolol on isoproterenol-induced myocardial infarction in arteriosclerotic and non-arteriosclerotic rats. , 1973, Atherosclerosis.

[30]  M. Davies.  The pathology of myocardial ischaemia. , 1977, Journal of clinical pathology. Supplement.